Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

NCT06362317 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Neoplasms Immunotherapy

Interventions

DRUG: Toripalimab
DRUG: Lenvatinib
DRUG: Gemox Chemotherapy（Gemox or GC）

Sponsor

Peking Union Medical College Hospital